Academic Journal
Q1Clinical Hematology International
About Clinical Hematology International
Clinical Hematology International is a scholarly journal published by Saabron Press. SCImago 2025 lists it in Q1, with an SJR of 0.806 and H-index of 11.
Coverage: 2022-2026. Research categories: Health Professions (miscellaneous) (Q1); Hematology (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2024-03-13. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Hematopoietic Stem Cell Transplantation; Multiple Myeloma Research and Treatments; Acute Myeloid Leukemia Research; CAR-T cell therapy research; Lymphoma Diagnosis and Treatment; Acute Lymphoblastic Leukemia research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-01. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Secondary failure of platelet recovery after allogeneic hematopoietic stem cell transplantation in pediatric acquired aplastic anemia: Incidence, risk factors, and clinical outcomes
Yue Shang, Yuanyuan Ren, Lipeng Liu, Xin Wang et al.
2026-09-30 · DOI: 10.46989/001c.171012Elranatamab in relapsed/refractory multiple myeloma patients on hemodialysis: A real-world case series
Hikmettullah Batgi, Fatoş Dilan Köseoğlu, Denis Çetin, Semih Başcı et al.
2026-09-28 · DOI: 10.46989/001c.171328Transplant outcomes after intensive chemotherapy or venetoclax plus azacitidine in acute myeloid leukemia: a multicenter retrospective study in Japan
Hiroyuki Muranushi, Junya Kanda, Tadakazu Kondo, Yasuyuki Arai et al.
2026-09-22 · DOI: 10.46989/001c.170281Healthcare professionals’ knowledge and attitudes toward the microbiome and fecal microbiotherapy or microbiota transfer in hematology and oncology: an international survey
Marion Larue, Giorgia Battipaglia, Hendrik Poeck, Riccardo Masetti et al.
2026-09-16 · DOI: 10.46989/001c.166241Delphi expert consensus on phlebotomy limitations and treatment challenges in HFE -related hemochromatosis
Jeremy Shearman, Domenico Girelli, Dominik J. Schaer, Sant-Rayn Pasricha et al.
2026-08-26 · DOI: 10.46989/001c.166769Iron deficiency without anemia: An underrecognized and undertreated clinical condition with special focus on colorectal cancer
Naga P. Raja, Nagapavani Kandagari
2026-08-05 · DOI: 10.46989/001c.165952Incidental perioperative detection of congenital methemoglobinemia: A prospective case series from a South Indian referral centre
Pooja Pushparaj, Aboobacker Mohamed Rafi
2026-07-31 · DOI: 10.46989/001c.164967Natural killer cells from patients relapsing on daratumumab therapy express an exhausted-associated phenotype
Katrine Fladeland Iversen, Line Nederby, Thomas Lund, Trine Andreasen Leth et al.
2026-07-07 · DOI: 10.46989/001c.163405Current landscape of academic and point of care CAR-T cell therapy in low-middle income countries
Sofía I. Quezada-Ramírez, José E. Montelongo-Cepeda, Gabriel A. González-López, Rosario Salazar-Riojas et al.
2026-06-29 · DOI: 10.46989/001c.163505The International Academy for Clinical Hematology (IACH) 2026–2030 strategic vision and roadmap: Building the global reference for education, collaboration, and innovation in clinical hematology
Mohamad Mohty, Bipin Savani, Ali Bazarbachi, Didier Blaise et al.
2026-06-15 · DOI: 10.46989/001c.163209Comparison of patient, hospitalization and center characteristics from the EMMY centers, IFM centers, and all multiple myeloma centers in France
Decaux Olivier, Ronan GARLANTEZEC, Aurore PERROT, Margaret MACRO et al.
2026-05-26 · DOI: 10.46989/001c.161361Allogeneic hematopoietic stem cell transplantation for VEXAS syndrome: A review and a case report
Kentaro Nagae, Hiroyuki Muranushi, Yasuhito Nannya, Takeshi Maeda et al.
2026-05-26 · DOI: 10.46989/001c.161719Is Pseudo-progression post-CAR T therapy real?
Alicia Shin, Kian Rahbari, Wichai Chinratanalab, Bipin Savani et al.
2026-05-12 · DOI: 10.46989/001c.160121Guidelines and consensus for minimal residual disease-adapted therapy in multiple myeloma from the Pan-Pacific multiple myeloma working group
Wenming Chen, Zhen Cai, Chor Sang Chim, Wee Joo Chng et al.
2026-05-04 · DOI: 10.46989/001c.160933Bladder mass following bone marrow transplant for sickle cell disease: A diagnostic dilemma
Yusuf Adelabu, Ugonna O. Fakile, Wale Q. Oladimeji, Kayode Oseni et al.
2026-05-04 · DOI: 10.46989/001c.161296Should monitoring guidelines and decision to treat for IgM MGUS be different when caring for Jehovah’s Witness patients?
Marshall Rosenberg, Alisha P. Maity, Karthik Shankar, Caroline Dunne et al.
2026-04-23 · DOI: 10.46989/001c.158440Disseminated adenovirus infection following CAR T-cell therapy: Early-onset presentation in a patient with relapsed refractory mantle cell lymphoma
Anusha Gopalam, Noha Soror, Aqsa Ashraf, Emily Siegrist et al.
2026-03-30 · DOI: 10.46989/001c.157628Leukemia cutis and all-trans retinoic acid–induced myocarditis in acute promyelocytic leukemia
Kian J. Rahbari, Parth C. Patel, Sarah Profitt, Justin T. Kelley et al.
2026-03-26 · DOI: 10.46989/001c.158170MajesTEC-3: Redefining what’s possible in multiple myeloma
Samer Al Hadidi, Mahmoud Gaballa
2026-03-12 · DOI: 10.46989/001c.158751Co-occurrence of angioimmunoblastic T-cell lymphoma and aggressive-refractory plasma-cell neoplasm: Two new cases and literature review
M. Christina Cox, Claudia Seimonte, Erica Giacobbi, Gianmario Pasqualone et al.
2026-03-11 · DOI: 10.46989/001c.158183Reviews
Community Reviews
Version History
October 4, 2026 at 9:04 pm
October 2, 2026